Entrada Therapeutics (TRDA) Asset Utilization Ratio (2023 - 2026)
Entrada Therapeutics' quarterly Asset Utilization Ratio came in at 0.02 in Q1 2026, down 95.27% year-on-year from 0.34 in Q1 2025, and down 74.98% quarter-over-quarter from 0.06 in Q4 2025.
Entrada Therapeutics has reported Asset Utilization Ratio for 4 years, with the latest figure at 0.02 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio fell 95.27% year-over-year to 0.02; the trailing twelve-month figure through Mar 2026 stood at 0.02 (down 95.27% YoY), and the FY2025 full-year result was 0.06, down 86.71% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.02, down from 0.06 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.44 in Q2 2024, with the low at 0.02 in Q1 2026.
- Average Asset Utilization Ratio over 4 years is 0.22, with a median of 0.18 recorded in 2023.
- Year-over-year, Asset Utilization Ratio jumped 389.05% in 2024 and tumbled 95.27% in 2026.
- Tracing TRDA's Asset Utilization Ratio over 4 years: stood at 0.27 in 2023, then surged by 44.23% to 0.39 in 2024, then plunged by 83.5% to 0.06 in 2025, then plunged by 74.98% to 0.02 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.02 (Q1 2026), 0.06 (Q4 2025), and 0.14 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.85 |
| 10 | Entrada Therapeutics | 295.78 Mn | 295.78 Mn | - | 0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 0.06 |
| Sep 30, 2025 | 0.14 |
| Jun 30, 2025 | 0.17 |
| Mar 31, 2025 | 0.34 |
| Dec 31, 2024 | 0.39 |
| Sep 30, 2024 | 0.38 |
| Jun 30, 2024 | 0.44 |
| Mar 31, 2024 | 0.33 |
| Dec 31, 2023 | 0.27 |
| Sep 30, 2023 | 0.18 |
| Jun 30, 2023 | 0.09 |
| Mar 31, 2023 | 0.07 |